There has been only one previous study in China that has addressed the value of DCP at a single time point involving 336 HCC patients and 252 liver diseases controls, and the main conclusion was that the combination of DCP and AFP had a total sensitivity of 84%, which was higher than that of either DCP (74%) or AFP (62%) alone [23]. The gene discussed is AFP; the disease is hepatocellular carcinoma.